Denis Lacombe & Diego du Monceau on Voices4Philanthropy
What does it take to bring promising cancer research to the patients who need it most?
In the latest episode of Voices4Philanthropy, the podcast series by Rothschild & Co Belgium, Denis Lacombe, CEO of EORTC, and Diego du Monceau, Chair of the EORTC Cancer Research Fund (ECRF), sat down with Anne-Sophie Eymeoud, Finance and Philanthropy Leader at Rothschild & Co, to discuss the vital role of independent academic research in advancing cancer care.
The conversation explores why philanthropic support is essential for addressing unmet needs in oncology—particularly in areas that are often overlooked by traditional funding methods, including rare cancers, underrepresented patient populations, treatment optimisation, and de-escalation of treatment strategies that can improve patients’ quality of life.
Combining scientific discovery and promising research may not be enough. Transforming scientific discoveries into better outcomes for patients requires sustained investment and long-term commitment from supporters who believe in the value of independent cancer research.
Listen to the full podcast in French to discover how academic collaboration, scientific independence, and philanthropy work together to drive progress for patients across Europe and beyond.
You can also help support EORTC’s game-changing clinical research to unleash scientific breakthrough and transform cancer patients’ lives. Learn how to GET INVOLVED, or Make a Contribution Now.
Get Social